Should colorectal cancer screening be considered in elderly persons without previous screening?: A cost-effectiveness analysis

Annals of Internal Medicine

Volumn 160, Issue 11, 2014, Pages 750-759

  Van Hees, Frank ^a   Habbema, Dik F ^a   Meester, Reinier G ^a   Lansdorp Vogelaar, Iris ^a   Van Ballegooijen, Marjolein ^a   Zauber, Ann G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER INCIDENCE; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; COLONOSCOPY; COLORECTAL CANCER; COMORBIDITY; CONTROLLED STUDY; COST; COST EFFECTIVENESS ANALYSIS; EXPERIMENTAL STUDY; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SIGMOIDOSCOPY;

AGE FACTORS; AGED; AGED, 80 AND OVER; COLONOSCOPY; COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MASS SCREENING; QUALITY OF LIFE; SIGMOIDOSCOPY;

EID: 84901764473     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M13-2263     Document Type: Article

References (39)

1. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149:627-37. [PMID: 18838716]
2. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2008; 149:659-69. [PMID: 18838717]
3. Rozen P, Liphshitz I, Barchana M. The changing epidemiology of colorectal cancer and its relevance for adapting screening guidelines and methods. Eur J Cancer Prev. 2011;20:46-53. [PMID: 21102339]
4. Shellnut JK, Wasvary HJ, Grodsky MB, Boura JA, Priest SG. Evaluating the age distribution of patients with colorectal cancer: are the United States Preventative Services Task Force guidelines for colorectal cancer screening appropriate? Dis Colon Rectum. 2010;53:5-8. [PMID: 20010343]
5. Shapiro JA, Klabunde CN, Thompson TD, Nadel MR, Seeff LC, White A. Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev. 2012;21: 895-904. [PMID: 22490320]
6. Goodwin JS, Singh A, Reddy N, Riall TS, Kuo YF. Overuse of screening colonoscopy in the Medicare population. Arch Intern Med. 2011;171:1335-43. [PMID: 21555653]
7. Ko CW, Sonnenberg A. Comparing risks and benefits of colorectal cancer screening in elderly patients. Gastroenterology. 2005;129:1163-70. [PMID: 16230070] (Pubitemid 41446856)
8. Lin OS, Kozarek RA, Schembre DB, Ayub K, Gluck M, Drennan F, et al. Screening colonoscopy in very elderly patients: prevalence of neoplasia and estimated impact on life expectancy. JAMA. 2006;295:2357-65. [PMID: 16720821] (Pubitemid 43788103)
9. Warren JL, Klabunde CN, Mariotto AB, Meekins A, Topor M, Brown ML, et al. Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med. 2009;150:849-57. [PMID: 19528563]
10. Rutter CM, Johnson EA, Feuer EJ, Knudsen AB, Kuntz KM, Schrag D. Secular trends in colon and rectal cancer relative survival. J Natl Cancer Inst. 2013;105:1806-13. [PMID: 24174654]
11. Blatt LJ. Polyps of the colon and rectum: incidence and distribution. Dis Colon Rectum. 1961;4:277-82.
12. Arminski TC, McLean DW. Incidence and distribution of adenomatous polyps of the colon and rectum based on 1,000 autopsy examinations. Dis Colon Rectum. 1964;7:249-61. [PMID: 14176135]
13. Bombi JA. Polyps of the colon in Barcelona, Spain. An autopsy study. Cancer. 1988;61:1472-6. [PMID: 3345499] (Pubitemid 18076428)
14. Chapman I. Adenomatous polypi of large intestine: incidence and distribution. Ann Surg. 1963;157:223-6. [PMID: 14020146]
15. Clark JC, Collan Y, Eide TJ, Estève J, Ewen S, Gibbs NM, et al. Prevalence of polyps in an autopsy series from areas with varying incidence of large-bowel cancer. Int J Cancer. 1985;36:179-86. [PMID: 4018911] (Pubitemid 15243443)
16. Jass JR, Young PJ, Robinson EM. Predictors of presence, multiplicity, size and dysplasia of colorectal adenomas. A necropsy study in New Zealand. Gut. 1992;33:1508-14. [PMID: 1452076]
17. Johannsen LG, Momsen O, Jacobsen NO. Polyps of the large intestine in Aarhus, Denmark. An autopsy study. Scand J Gastroenterol. 1989;24:799-806. [PMID: 2799283] (Pubitemid 19226933)
18. Rickert RR, Auerbach O, Garfinkel L, Hammond EC, Frasca JM. Adenomatous lesions of the large bowel: an autopsy survey. Cancer. 1979;43:1847-57. [PMID: 445371] (Pubitemid 9203736)
19. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 9 Regs Limited Use, Nov 2002 Sub (1973-2000). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. Released April 2003, based on the November 2002 submission.
20. Vatn MH, Stalsberg H. The prevalence of polyps of the large intestine in Oslo: an autopsy study. Cancer. 1982;49:819-25. [PMID: 7055790] (Pubitemid 12165443)
21. Williams AR, Balasooriya BA, Day DW. Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut. 1982;23:835-42. [PMID: 7117903] (Pubitemid 12018511)
22. Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, et al UK Flexible Sigmoidoscopy Trial Investigators. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010;375:1624-33. [PMID: 20430429]
23. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472-7. [PMID: 8942775] (Pubitemid 26400242)
24. Jørgensen OD, Kronborg O, Fenger C. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut. 2002;50:29-32. [PMID: 11772963] (Pubitemid 34028299)
25. Lansdorp-Vogelaar I, van Ballegooijen M, Boer R, Zauber A, Habbema JD. A novel hypothesis on the sensitivity of the fecal occult blood test: results of a joint analysis of 3 randomized controlled trials. Cancer. 2009;115:2410-9. [PMID: 19288570]
26. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst. 1999;91:434-7. [PMID: 10070942] (Pubitemid 29128279)
27. Cho H, Klabunde CN, Yabroff KR, Wang Z, Meekins A, Lansdorp-Vogelaar I, et al. Comorbidity-adjusted life expectancy: a new tool to inform recommendations for optimal screening strategies. Ann Intern Med. 2013;159: 667-76. [PMID: 24247672]
28. Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR; United States Multi-Society Task Force on Colorectal Cancer. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012;143:844-57. [PMID: 22763141]
29. Ness RM, Holmes AM, Klein R, Dittus R. Utility valuations for outcome states of colorectal cancer. Am J Gastroenterol. 1999;94:1650-7. [PMID: 10364039] (Pubitemid 29260460)
30. Bureau of Labor Statistics. Current Employment Statistics (National). Accessed at www.bls.gov/web/empsit/ceseesummary.htm on 16 January 2013.
31. Yabroff KR, Lamont EB, Mariotto A, Warren JL, Topor M, Meekins A, et al. Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst. 2008;100:630-41. [PMID: 18445825]
32. Zauber AG, Lansdorp-Vogelaar I, Wilschut J, Knudsen AB, Ballegooijen Mv, Kuntz KM. Cost-effectiveness of DNA stool testing to screen for colorectal cancer. Rockville, MD: Agency for Healthcare Research and Quality; 2007. Accessed at www.cms.gov/Medicare/Coverage/DeterminationProcess/downloads/id52TA. pdf on 3 April 2014.
33. Leffler DA, Kheraj R, Garud S, Neeman N, Nathanson LA, Kelly CP, et al. The incidence and cost of unexpected hospital use after scheduled outpatient endoscopy. Arch Intern Med. 2010;170:1752-7. [PMID: 20975024]
34. Bureau of Labor Statistics. Consumer Price Index. Accessed at www.bls.gov/cpi/ on 23 September 2013.
35. Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Boer R, Wilschut J, Winawer SJ, et al. Individualizing colonoscopy screening by sex and race. Gastrointest Endosc. 2009;70:96-108, 108.e1-24. [PMID: 19467539]
36. Freedman AN, Slattery ML, Ballard-Barbash R, Willis G, Cann BJ, Pee D, et al. Colorectal cancer risk prediction tool for white men and women without known susceptibility. J Clin Oncol. 2009;27:686-93. [PMID: 19114701]
37. Gatto NM, Frucht H, Sundararajan V, Jacobson JS, Grann VR, Neugut AI. Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst. 2003;95:230-6. [PMID: 12569145] (Pubitemid 36240636)
38. Painter J, Saunders DB, Bell GD, Williams CB, Pitt R, Bladen J. Depth of insertion at flexible sigmoidoscopy: implications for colorectal cancer screening and instrument design. Endoscopy. 1999;31:227-31. [PMID: 10344426]
39. van Rijn JC, Reitsma JB, Stoker J, Bossuyt PM, van Deventer SJ, Dekker E. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol. 2006;101:343-50. [PMID: 16454841]